{"id":61006,"date":"2025-03-29T13:02:48","date_gmt":"2025-03-29T12:02:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/"},"modified":"2025-03-29T13:02:48","modified_gmt":"2025-03-29T12:02:48","slug":"concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/","title":{"rendered":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers"},"content":{"rendered":"
\n

\nCloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging<\/i>\n<\/p>\n

CAMBRIDGE, Mass. & LOUISVILLE, Ky.–(BUSINESS WIRE)–ConcertAI’s TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR\u00ae<\/sup> Labs, a leading provider of 3D medical image post-processing and clinically integrated AI services in the United States. This collaboration aims to enhance clinical service delivery for advanced imaging by expanding the range of domain-specific workflows and clinical AI technologies. As a result, it will benefit numerous hospitals across the country.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe foundation of this partnership is TeraRecon’s new TRSubscription\u2122 offering, which grants 3DR Labs access to a comprehensive suite of advanced visualization tools, AI-powered clinical applications, and cloud services, all under a unified model. By integrating clinical AI and cloud technologies, both companies aim to equip healthcare providers with the latest innovations in imaging diagnostics and surgical planning. Additionally, TeraRecon will become a founding member of 3DR’s AI Labs, a vendor-agnostic services platform designed for universal workflow integration using AI.\n<\/p>\n

\n\u201cOur partnership with 3DR addresses critical industry challenges, including increased pressure on hospital resources, rising demand for complex imaging analysis services, and the need for practical AI applications with validated clinical benefits,\u201d said Dhiraj Carumbaya, SVP & GM for ConcertAI\u2019s TeraRecon business. \u201cOur new technology subscription gives customers full access to a range of clinical applications to comprehensively deliver exceptional service across their imaging enterprise.\u201d\n<\/p>\n

\nThe partnership will help transition 3DR’s clinical operations to the Cloud, an integral component of the TRSubscription\u2122. This migration will streamline the interaction between 3DR Labs and its hospital clients by enabling secure, cloud-based data transmission and remote visualization capabilities, enhancing 3DR Labs’ ability to scale its services while maintaining the highest clinical quality and data security standards.\n<\/p>\n

\n\u201cAs demand for advanced medical imaging analysis continues to grow, this partnership allows 3DR Labs to stay at the forefront of innovation,\u201d said Mike Jackman, CEO of 3DR Labs. \u201cHigh-quality, outsourced 3D medical imaging services and AI-enabled insights enhance our ability to serve our hospital partners efficiently. By leveraging TeraRecon\u2019s technology and partnering to offer AI as-a-service, we can scale our operations to meet increasing clinical needs while maintaining our commitment to exceptional quality and service.\u201d\n<\/p>\n

\nTeraRecon’s new TRSubscription\u2122 introduces cutting-edge advancements in AI for image processing technologies and clinical workflows throughout the imaging enterprise. This solution enables 3DR Labs to reinforce its leadership in offering clinical services for medical imaging post-processing and innovative surgical planning for hospitals. Visit TeraRecon at ACC2025, booth 17009, to learn more.\n<\/p>\n

\nAbout ConcertAI<\/b>\n<\/p>\n

\nConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai\u2122 technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ\u00ae<\/sup> is an initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified\u00ae<\/sup> quality solutions and SmartLinQ\u2122 analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com<\/a>.\n<\/p>\n

\nAbout 3DR Labs<\/b>\n<\/p>\n

\nHeadquartered in Louisville, Kentucky, 3DR Labs, LLC provides round-the-clock access to more than 250 expert radiologic technologists, cutting-edge imaging software, and advanced clinical AI workflow solutions. 3DR\u2019s AI Labs, a vendor-agnostic services platform, connects imaging departments to a gateway of 3D workflow automation, delivering quality, speed, and efficiency within medical imaging systems. Founded in 2005, 3DR Labs provides services to over a thousand hospital imaging departments, stand-alone imaging centers, and radiology practices. Turnaround times for CT and MRI exams are guaranteed within hours or even minutes. For more information, please visit https:\/\/3drlabs.com\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTreble<\/a>
McKenzie Covell
\n
concertai@treblepr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging CAMBRIDGE, Mass. & LOUISVILLE, Ky.–(BUSINESS WIRE)–ConcertAI’s TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR\u00ae Labs, a leading provider of 3D medical image post-processing and clinically integrated AI … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61006","6":"format-standard","7":"category-industry"},"yoast_head":"\nConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging CAMBRIDGE, Mass. & LOUISVILLE, Ky.–(BUSINESS WIRE)–ConcertAI’s TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR\u00ae Labs, a leading provider of 3D medical image post-processing and clinically integrated AI ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-29T12:02:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers\",\"datePublished\":\"2025-03-29T12:02:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250329672037\\\/en\\\/2423747\\\/22\\\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/\",\"name\":\"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250329672037\\\/en\\\/2423747\\\/22\\\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg\",\"datePublished\":\"2025-03-29T12:02:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250329672037\\\/en\\\/2423747\\\/22\\\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250329672037\\\/en\\\/2423747\\\/22\\\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/","og_locale":"en_US","og_type":"article","og_title":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend","og_description":"Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging CAMBRIDGE, Mass. & LOUISVILLE, Ky.–(BUSINESS WIRE)–ConcertAI’s TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR\u00ae Labs, a leading provider of 3D medical image post-processing and clinically integrated AI ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/","og_site_name":"Pharma Trend","article_published_time":"2025-03-29T12:02:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers","datePublished":"2025-03-29T12:02:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/"},"wordCount":671,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/","url":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/","name":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg","datePublished":"2025-03-29T12:02:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250329672037\/en\/2423747\/22\/logo-TeraRecon-ConcertAI-fullColor-rgb_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/concertais-terarecon-and-3dr-labs-announce-expanded-partnership-to-transform-the-delivery-of-ai-enabled-image-post-processing-clinical-services-for-us-healthcare-providers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ConcertAI\u2019s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61006"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61006\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}